Results 251 to 260 of about 97,265 (298)

Orbital radiotherapy with combined intravenous methylprednisolone and mycophenolate mofetil in moderate-to-severe thyroid eye disease

open access: diamond
Kenneth Ka Hei Lai   +13 more
openalex   +1 more source

Puzzling Late Relapse of Thyroid Eye Disease: A Case Series. [PDF]

open access: yesJCEM Case Rep
Oustabassidis E   +3 more
europepmc   +1 more source

Deep Learning-Driven Exophthalmometry through Facial Photographs in Thyroid Eye Disease. [PDF]

open access: yesOphthalmol Sci
Park J   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Thyroid Eye Disease

Neurologic Clinics, 2010
Thyroid eye disease (TED) is the most common cause of proptosis in adults, and should always be a consideration in patients with unexplained diplopia, pain, or optic nerve dysfunction. At least 80% of TED is associated with Graves disease (GD), and at least 50% of patients with GD develop clinically evident symptomatic TED.
Kimberly P, Cockerham, Stephanie S, Chan
  +5 more sources

Thyroid eye disease

BMJ, 2009
Thyroid eye disease is a relatively rare condition, with an incidence of 2.9 to 16.0 cases per 100 000 population per year.1 The disease mainly affects women. Many patients experience distressing symptoms, and a few develop sight threatening complications. Patients are often young or middle aged and at the peak of their career.
Petros, Perros   +2 more
openaire   +4 more sources

Thyroid Eye Disease

2019
Thyroid eye disease (TED), also known as thyroid-associated orbitopathy (TAO), is a chronic inflammation of the orbital tissues. It is an autoimmune process that mostly affects patients with Graves’ disease, but it can also affect patients with other autoimmune disorders of the thyroid.
Shantha Amrith   +5 more
  +6 more sources

Home - About - Disclaimer - Privacy